Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

Tenax Therapeutics, Inc. (TENX)

Compare
6.30
-0.04
(-0.63%)
At close: 4:00:00 PM EDT
6.30
0.00
(0.00%)
After hours: 4:05:11 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
19,494
19,494
8,234
11,052.64
32,728.24
Operating Income
-19,494
-19,494
-8,234
-11,052.64
-32,728.24
Net Non Operating Interest Income Expense
1,891
1,891
460
-4.44
-0.95
Other Income Expense
1
1
63
9.19
254.83
Pretax Income
-17,602
-17,602
-7,711
-11,047.90
-32,474.36
Net Income Common Stockholders
-17,602
-17,602
-7,711
-11,047.90
-32,474.36
Diluted NI Available to Com Stockholders
-17,602
-17,602
-7,711
-11,047.90
-32,474.36
Basic EPS
-13.05
-1.15
-31.04
-600.71
-2.52k
Diluted EPS
-13.05
-1.15
-31.04
-600.71
-2.52k
Basic Average Shares
6,286.30
15,271.71
248.45
18.39
12.86
Diluted Average Shares
6,286.30
15,271.71
248.45
18.39
12.86
Total Operating Income as Reported
-19,494
-19,494
-8,234
-11,052.64
-32,728.24
Total Expenses
19,494
19,494
8,234
11,052.64
32,728.24
Net Income from Continuing & Discontinued Operation
-17,602
-17,602
-7,711
-11,047.90
-32,474.36
Normalized Income
-17,602
-17,602
-7,711
-11,047.90
-32,474.36
Interest Income
1,914
1,914
484
--
--
Interest Expense
23
23
24
4.44
0.95
Net Interest Income
1,891
1,891
460
-4.44
-0.95
EBIT
-17,579
-17,579
-7,687
-11,043.45
-32,473.41
EBITDA
-17,579
-17,579
-7,679
-10,930.12
-32,364.43
Reconciled Depreciation
--
--
8
113.33
108.98
Net Income from Continuing Operation Net Minority Interest
-17,602
-17,602
-7,711
-11,047.90
-32,474.36
Normalized EBITDA
-17,579
-17,579
-7,679
-10,930.12
-32,364.43
12/31/2021 - 4/4/1994

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VTVT vTv Therapeutics Inc.
17.50
+6.71%
 
AKTX Akari Therapeutics, Plc
1.1000
-4.35%
 
PULM Pulmatrix, Inc.
6.06
-2.26%
 
TYRA Tyra Biosciences, Inc.
8.65
-0.80%
 
PALI Palisade Bio, Inc.
0.6676
-0.33%
 
ZVSA ZyVersa Therapeutics, Inc.
0.5873
-0.03%
 
ENSC Ensysce Biosciences, Inc.
2.6400
+5.60%
 
ATXI Avenue Therapeutics, Inc.
0.2621
-12.63%
 
BPTH Bio-Path Holdings, Inc.
0.1702
+3.15%
 
MLYS Mineralys Therapeutics, Inc.
14.00
+1.16%